Status:
UNKNOWN
Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Oligohydramnios
Polyhydramnios
Eligibility:
FEMALE
18+ years
Brief Summary
To evaluate and compare fetal cardiac performance by fetal echocardiography and delivery outcome between fetuses with isolated oligohydramnios, normal amniotic fluid and polyhydramnios.
Eligibility Criteria
Inclusion
- Gestational age 24-42 weeks
- Singleton pregnancies
Exclusion
- Fetal anatomical or chromosomal abnormality
- Known fetal cardiac defect
- Suspected fetal infection
- Suspected IUGR
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03277417
Start Date
September 1 2017
End Date
September 1 2019
Last Update
September 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100